We are developing a new environmentally friendly technology to replace the existing high energy time-consuming procedure in the greenhouses, to help the farmers grow plants faster with better quality and less consumption of energy. Our treatment can be used to control plant size, quality, and speed of growth, and also to preserve plants for a long period.

In this industry, we are not required to disclose the content of the products we sell. There are no requirements for the production, process, or raw material before the products are sold. The vagina is the most absorbent organ you have. If the products you use contain potentially toxic chemicals, you may run the risk of getting them right into your bloodstream. With this in mind as well as an idea for more transparent and to-the-point marketing, the founder of Flove, Jeanett wanted to develop a well-documented menstrual cup, of high quality and without toxic chemicals. After 2,5 years of testing, prototyping, failing, and researching Flove menstrual cup finally launched in May 2019. The cups are designed and developed in Norway and are produced in a certified "clean room" in Taiwan. Jeanette visited the factory in March 2019. The silicone used is certified medical-grade silicone from Dow Corning. The bag coming with the menstrual cup when buying one is made of lyocell Tencel, printed and sewn at Fabrikk Oslo. The packaging is made of carton and is printed at 07 media in Oslo. The goal is to make menstrual cup mainstream and to sell more sustainable products. *  One of the reasons Flove was established was to help girls to stay in school around the world. There are so many girls who can't afford sanitary pads and the result is often that many girls drop out of school. We are looking for the right partner to help us help as many girls as possible to stay in school.

OM RUBYNOR AS Kontakt Ole Morten Amundsen på oma@rubynor.com Vi bygger startups! Vi er en dyktig gjeng med utviklere som har troen på seg selv og våre skills med lean startup. Det eneste som mangler er om vi også er hyggelige og har det gøy. team in office Humor er viktig, for startups are hard! Med oss på laget har du startupproffer med god track-record. Med oss som dine kollegaer har du et åpent og ærlig miljø som omfavner utfordringer og usikkerhet, med pågangsmot og trygghet om "dette klarer vi".

Cloud-native microenvironment control for developing & scaling complex cell models. We offer solutions for vertically integrating 2D and 3D assays into your workflow, all the while you maintain real-time control over relevant readouts and variables. Find out more on www.vitroscope.no or reach out under contact@vitroscope.no

Sensar Marine is set out to revolutionize the boating industry. Using the latest sensor and wireless technology we will improve safety at sea, protect the boat when not in use and give boat owners and their families peace of mind wherever they are. Sensar Marine makes products designed to improve the relationship between a boat and its owner. Our flagship product is a boat monitoring system designed specifically for use in boats, which could run 24/7, 365 days a year without draining boat batteries. Our service has introduced a way for boaters to monitor their boats from their mobile phones, and be notified when their boat needs attention. To date, SmartBoat One has been installed in thousands of boats of all types, in harbors around the world.

Waste management solutions. Primary machines and equipment, but also consulting. We make a profit by helping customers reduce their costs (and even make a profit). Enterprises can save/make money by focusing on the environment.  Both parties win. Eco-Nor Group may consider investors to cooperate with good and long-term partners as a matter of urgency.

Tour operator offering unique hiking experiences in Oslo. We offer group tours, private tours, events and arrangements outdoors in the most beautiful places around Oslo. Imagine untouched forests, stunning views of Oslo fjord, mountains in Bergen, fresh water lakes... Hiking in Oslo and Bergen is an easy and fun way to enjoy Norwegian nature. Just put on your walking shoes and join our guided tours!

eCommerce, B2B, and product development towards tactical, outdoor, and lifestyle products. Office and warehouse in Oslo and eCommerce presence 3 in Norway, Sweden, and Finland. 25 employees and 100MNOK revenue in 2018. We've been growing about 50% yearly over the last three years and aim to continue growing at the same speed. The young data-driven organization with ambitions to become the biggest player within our niche. Come and join us!

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

We provide the banking network, messaging, settlement, and cash management solutions to meet any bank’s requirements. We are based in Fredrikstad, Norway, where UNITE evolved as a correspondent hub for banks, but our origin is global, developed over years in international banking centers. We have studied other initiatives over the years and learned that the third-party philosophy of trying to bolt-on smart software to multiple bank accounts is less than ideal. A holistic revolution was required to deliver a cross-border payments solution fit for banks in the 21st century.

The Norgeskart app for iPhone and iPad is the most detailed map of Norway. Norgeskart is suitable for hikers, tourists, and city walkers. • Comprehensive, accurate maps of Norway are delivered by Kartverket • Download the map for offline use • GPS navigation with auto-rotating map and compass • Search for places and addresses • Detailed trails for hiking, biking, and walking • Accurate sea maps along the Norwegian coast • Ad-free experience

Octaos is an IT development company, creating modern web-based products to support the processes of the building industry. We make online graphical product configurators fully integrated with the manufactures ERP-systems, for use in both for the professional and the consumer market. Today we have customers in Norway, Sweden and in the UK, - and we have plans to soon grow beyond these business areas.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

Five seasoned experts with over 175 years of experience in the oil & gas industry have developed a new patent pending disruptive revolutionary technology.   Water is separated in a horizontal well bore close to the reservoir and thereafter re-injected via a lateral well as pressure support to increase oil recovery. The Fluidsep DPP combines production and injection in one well with no spill to the surface, all excess water and sand is re-injected and never sees the surfaceThe technology enables  35% extra oil production and at the same time results in significantly reduced CO2/barrel of Oil. More than a 30% reduction compared with conventional production. An example of simulations shows extra income of > 1 Billion NOK per well. Fluidsep DPP has achieved TRL 2 - and requires 2 years of qualifications and pilot testing to be ready for the market, TRL 7. Strong interest in the market about our technology. Currently inviting investors and Seed capital funds to participate in the joint development of building a new international downhole service provider based in the Bergen region.

MYREZE AS is an international broadcast design company with headquarters in Norway. Our main focus is branding and opening titles for film and TV. Our expertise includes everything from professional music videos to comprehensive corporate rebranding, working relentlessly to deliver outcomes of the highest quality for our clients. Our mission is to develop and brand movies and TV in the most profound and innovative way in order to create a stronger identity targeted toward their respective audiences.